Research Progress of Tumor Microenvironment Targeted Therapy for Clear Cell Renal Cell Carcinoma

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• Renal clear cell carcinoma (ccRCC) is significantly influenced by its tumor microenvironment (TME).
• Understanding the TME-ccRCC interaction is crucial for developing effective therapeutic strategies.
• Current treatments like tyrosine kinase inhibitors and immune checkpoint inhibitors show promise but highlight the need for more targeted approaches.

Approach:

• This review synthesizes current knowledge on the ccRCC tumor microenvironment.
• It examines the outcomes of various treatment modalities.
• The review identifies and discusses potential therapeutic targets within the TME.

Key Points:

• The TME plays a critical role in ccRCC progression and treatment response.
• Targeted therapies focusing on specific TME components represent a novel and evolving treatment strategy.
• Research into TME-ccRCC interactions is a rapidly advancing field with significant clinical implications.

Conclusions:

• The TME is a key determinant in ccRCC, influencing treatment efficacy.
• Targeting the TME offers a promising avenue for novel ccRCC therapies.
• Further research into TME components is essential for advancing ccRCC treatment.